Thomas Flaten
Stock Analyst at Lake Street
(3.10)
# 1,315
Out of 5,043 analysts
31
Total ratings
42.42%
Success rate
4.51%
Average return
Main Sectors:
Stocks Rated by Thomas Flaten
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EVAX Evaxion | Maintains: Buy | $6 → $11 | $6.13 | +79.45% | 3 | Oct 20, 2025 | |
| HROW Harrow | Maintains: Buy | $42 → $70 | $38.24 | +83.05% | 1 | Sep 29, 2025 | |
| DERM Journey Medical | Maintains: Buy | $9 → $13 | $8.02 | +62.09% | 2 | Aug 13, 2025 | |
| RPID Rapid Micro Biosystems | Initiates: Buy | $8 | $2.95 | +171.19% | 1 | Jul 28, 2025 | |
| DMAC DiaMedica Therapeutics | Maintains: Buy | $11 → $14 | $6.88 | +103.49% | 2 | Jul 18, 2025 | |
| AYTU Aytu BioPharma | Initiates: Buy | $8 | $2.21 | +261.99% | 1 | Jul 1, 2025 | |
| BDSX Biodesix | Maintains: Buy | $60 → $40 | $6.65 | +501.50% | 1 | May 14, 2025 | |
| CSTL Castle Biosciences | Maintains: Buy | $40 → $35 | $23.96 | +46.08% | 6 | May 6, 2025 | |
| AQST Aquestive Therapeutics | Maintains: Buy | $10 → $8 | $7.00 | +14.29% | 2 | Mar 7, 2025 | |
| PSNL Personalis | Maintains: Buy | $7 → $9 | $9.68 | -7.02% | 2 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $3 | $0.81 | +269.78% | 3 | Mar 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $11 | $4.68 | +135.04% | 3 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $25 | $28.04 | -10.84% | 2 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14,400 → $1,440 | $2.14 | +67,189.72% | 2 | Nov 17, 2022 |
Evaxion
Oct 20, 2025
Maintains: Buy
Price Target: $6 → $11
Current: $6.13
Upside: +79.45%
Harrow
Sep 29, 2025
Maintains: Buy
Price Target: $42 → $70
Current: $38.24
Upside: +83.05%
Journey Medical
Aug 13, 2025
Maintains: Buy
Price Target: $9 → $13
Current: $8.02
Upside: +62.09%
Rapid Micro Biosystems
Jul 28, 2025
Initiates: Buy
Price Target: $8
Current: $2.95
Upside: +171.19%
DiaMedica Therapeutics
Jul 18, 2025
Maintains: Buy
Price Target: $11 → $14
Current: $6.88
Upside: +103.49%
Aytu BioPharma
Jul 1, 2025
Initiates: Buy
Price Target: $8
Current: $2.21
Upside: +261.99%
Biodesix
May 14, 2025
Maintains: Buy
Price Target: $60 → $40
Current: $6.65
Upside: +501.50%
Castle Biosciences
May 6, 2025
Maintains: Buy
Price Target: $40 → $35
Current: $23.96
Upside: +46.08%
Aquestive Therapeutics
Mar 7, 2025
Maintains: Buy
Price Target: $10 → $8
Current: $7.00
Upside: +14.29%
Personalis
Jan 8, 2025
Maintains: Buy
Price Target: $7 → $9
Current: $9.68
Upside: -7.02%
Mar 12, 2024
Maintains: Buy
Price Target: $4 → $3
Current: $0.81
Upside: +269.78%
Mar 5, 2024
Maintains: Buy
Price Target: $19 → $11
Current: $4.68
Upside: +135.04%
Aug 9, 2023
Maintains: Buy
Price Target: $34 → $25
Current: $28.04
Upside: -10.84%
Nov 17, 2022
Maintains: Buy
Price Target: $14,400 → $1,440
Current: $2.14
Upside: +67,189.72%